Mark A Lemmon, PhD, FRS

David A. Sackler Professor of Pharmacology; Co-director, Cancer Biology Institute

Departments & Organizations

Pharmacology: Primary Faculty

Yale Cancer Center: Signal Transduction | Yale CTAP

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Biochemistry, Biophysics and Structural Biology: Cell Cycle and Signal Transduction; Drug Design, Discovery and Mechanism; Membrane Biology and Motion | Molecular Medicine, Pharmacology, and Physiology: Cancer Biology and Therapeutics; Structural Biology

Biography

Mark Lemmon, PhD was appointed the Co-Director of the Cancer Biology Institute and the David A. Sackler Professor of Pharmacology in 2015. Dr. Lemmon returns to Yale, where he completed his PhD in 1993, from the University of Pennsylvania’s Perelman School of Medicine. At UPenn, he was the George W. Raiziss Professor of Biochemistry and Biophysics as well as Chair of the department and an Investigator at the Abramson Family Cancer Research Institute. Dr. Lemmon’s research focuses on the signaling pathways of receptor tyrosine kinases (RTKs), which, when mutated cause cancers and other diseases.

Education & Training

PhD Yale University (1993)
BA Oxford University (Hertford College), Biochemistry (1988)

Edit this profile

Contact Info

Mark A Lemmon, PhD, FRS
Office Locations
Medical School OfficeSterling Hall of Medicine, B-Wing
333 Cedar Street, Fl 3 Rm 326A

New Haven, CT 06510
View on map...
Cancer Biology Institute OfficeWest Campus Advanced Biosciences Center
840 West Campus Drive, Fl 3 Rm 301

West Haven, CT 06516
View on map...
Mailing Address
Department of Pharmacology, Yale University School of Medicine
B326A Sterling Hall of Medicine

New Haven, CT 06520-8066